Finzati - Logo
ENVB logo

Enveric Biosciences, Inc.

ENVBBiotechnology
$0.00
0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$805,966
Growth
-100.0%
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0Healthy liquidity · 5.38Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 19, 2026, 12:23 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$0.00
Change0.00%
Market Cap$805.97K
52W Range1.25 - 17.64
Beta1.13
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.00
Current Ratio5.38
Quick Ratio5.38
Revenue 5Y-100.00%

Investment DNA

How strong this company looks for long-term investors

47
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
70/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score
Manageable debt level · 0Healthy liquidity · 5.38Weak profitability
Analyst view
No analyst data available now.

Company Overview

IPO: 5/4/2015
Industry: Biotechnology
P/B i: 0.29
Debt / Equity i: 0.00
Operating Margin: 0.00%
Net Margin: 0.00%
ROE i: -
ROIC: -

Financial Health

Score14 / 20
Debt / Equity: 0.00
Current Ratio: 5.38
Quick Ratio: 5.38
Status: Good

Insider Transactions

Recent executive and insider activity

Coveney Kevin Michael
Transaction: 12/23/2025
BUY
Change
+40,198
Price
Not reported
Filing
12/30/2025
Type
BUY
WEBB MICHAEL D
Transaction: 12/23/2025
BUY
Change
+7,633
Price
Not reported
Filing
12/30/2025
Type
BUY
Tucker Joseph Edward
Transaction: 12/23/2025
BUY
Change
+60,296
Price
Not reported
Filing
12/30/2025
Type
BUY